• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease-Reply.

作者信息

Casella James F, Kronsberg Shari S, Gorney Rebecca T

机构信息

Johns Hopkins University School of Medicine, Baltimore, Maryland.

University of Massachusetts Medical School, Worcester.

出版信息

JAMA. 2021 Sep 14;326(10):975-976. doi: 10.1001/jama.2021.11103.

DOI:10.1001/jama.2021.11103
PMID:34519804
Abstract
摘要

相似文献

1
Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease-Reply.泊洛沙姆188与安慰剂治疗镰状细胞病儿童和成人疼痛性血管闭塞性发作的回复
JAMA. 2021 Sep 14;326(10):975-976. doi: 10.1001/jama.2021.11103.
2
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.聚氧乙烯月桂醚 188 对比安慰剂对镰状细胞病儿童和成人血管阻塞性危象疼痛的影响：一项随机临床试验。
JAMA. 2021 Apr 20;325(15):1513-1523. doi: 10.1001/jama.2021.3414.
3
Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
JAMA. 2021 Sep 14;326(10):975. doi: 10.1001/jama.2021.11100.
4
Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease.
JAMA. 2021 Sep 14;326(10):974-975. doi: 10.1001/jama.2021.11097.
5
Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial.用于治疗镰状细胞病急性血管闭塞性危象的纯化泊洛沙姆188：一项随机对照试验。
JAMA. 2001 Nov 7;286(17):2099-106. doi: 10.1001/jama.286.17.2099.
6
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.一项评估普拉格雷治疗镰状细胞血管阻塞事件的多国临床试验。
N Engl J Med. 2016 Feb 18;374(7):625-35. doi: 10.1056/NEJMoa1512021. Epub 2015 Dec 8.
7
Are there phases to the vaso-occlusive painful episode in sickle cell disease?镰状细胞病的血管闭塞性疼痛发作有阶段之分吗？
J Pain Symptom Manage. 2005 Apr;29(4):392-400. doi: 10.1016/j.jpainsymman.2004.07.006.
8
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.DOVE（确定血小板抑制对血管闭塞事件的影响）试验设计：一项全球性3期双盲、随机、安慰剂对照、多中心研究，采用剂量滴定策略评估普拉格雷在镰状细胞贫血儿科患者中的疗效和安全性。
Pediatr Blood Cancer. 2016 Feb;63(2):299-305. doi: 10.1002/pbc.25771. Epub 2015 Sep 24.
9
A holistic approach to vaso-occlusive pain crisis in children with sickle cell disease.针对镰状细胞病患儿血管阻塞性疼痛危象的整体治疗方法。
J Holist Nurs. 1992 Mar;10(1):62-75. doi: 10.1177/089801019201000107.
10
Effects of poloxamer 188 treatment on sickle cell vaso-occlusive crisis: computer-assisted intravital microscopy study.泊洛沙姆188治疗对镰状细胞血管闭塞性危象的影响：计算机辅助活体显微镜研究
J Investig Med. 2004 Sep;52(6):402-6. doi: 10.1136/jim-52-06-35.

引用本文的文献

1
Using disease-modifying therapies in sickle cell disease.在镰状细胞病中使用疾病修正疗法。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):519-531. doi: 10.1182/hematology.2023000485.
2
The challenge of clinical end points in sickle cell disease.镰状细胞病临床终点的挑战。
Blood. 2023 Dec 14;142(24):2047-2054. doi: 10.1182/blood.2023021220.